Evidence Level
L-Glutathione is a critical antioxidant that neutralizes free radicals and protects cellular components from oxidative damage. Historically, oral supplementation was considered ineffective due to gastrointestinal degradation; however, advancements in delivery methods have improved bioavailability. A randomized controlled trial by Richie et al. (2015) demonstrated that oral administration of glutathione at doses ranging from 250-1000 mg/day over six months significantly increased blood glutathione levels by 30-35%. This highlights the potential efficacy of optimized delivery forms such as liposomal and S-acetyl glutathione.
In addition to direct supplementation, N-Acetylcysteine (NAC) is a cost-effective alternative that stimulates endogenous glutathione production. Studies have shown its benefits in various clinical contexts: Dubey et al. (2025) found that a triple probiotic combination improved metabolic and oxidative stress parameters in diabetic populations, while Li et al. (2022) demonstrated that NAC supplementation enhanced reproductive health outcomes in advanced-age women undergoing IVF/ICSI cycles. However, not all studies have yielded positive results; for instance, Sitohang et al. (2021) found no significant skin-lightening benefits from oral glutathione supplementation in a trial involving 83 participants.
Overall, L-Glutathione and its derivatives hold promise as effective antioxidants, with their utility depending on the specific delivery method and clinical application.